Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigens

Rong Fu Wang, Xiang Wang, Samuel L. Johnston, Gang Zeng, Paul F. Robbins, Steven A. Rosenberg

Research output: Contribution to journalArticle

Abstract

A new retroviral system has been developed for the generation of a cDNA library and the functional cloning of tumor antigens. These retroviral vectors contain a cytomegalovirus promoter in the 5' long terminal repeat, an extended packaging signal for rapid production of high-titer retroviral particles, and many convenient cloning sites for cDNA library construction. The vesicular stomatitis virus G protein has been used to generate pseudotype retroviral particles to enable efficient viral infection. Using this system, viral titers in the range of 106 colony-forming units/ml could be generated routinely, and a high transduction efficiency inhuman primary cells, including fibroblasts, was achieved. In addition, a new procedure has been devised for screening a retrovirus-based cDNA library without a functional selection. The utility of this system was demonstrated by constructing a retrovirus-based cDNA library and re-isolating the NY-ESO-1 tumor antigen from a cDNA library using an antigen-specific CTL. This approach can facilitate the identification of novel tumor antigens recognized by T cells without knowledge of MHC class I restriction elements and is generally applicable for the isolation of any gene as long as a biological assay is available.

Original languageEnglish (US)
Pages (from-to)3519-3525
Number of pages7
JournalCancer Research
Volume58
Issue number16
StatePublished - Aug 15 1998

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigens'. Together they form a unique fingerprint.

  • Cite this

    Wang, R. F., Wang, X., Johnston, S. L., Zeng, G., Robbins, P. F., & Rosenberg, S. A. (1998). Development of a retrovirus-based complementary DNA expression system for the cloning of tumor antigens. Cancer Research, 58(16), 3519-3525.